NAFLD / MASLD · 3 minutes
Fatty liver (NAFLD / MASLD) risk screener
Eight quick questions about metabolic risk factors, alcohol use and known liver findings. Result tells you whether the standard liver workup (ultrasound + FibroScan + ALT/AST) is appropriate.
Your BMI
Educational tool — not a diagnosis. Risk-factor screener informed by AASLD 2023 MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease) practice guidance. Confirmatory diagnosis requires imaging (ultrasound or MRI-PDFF) and / or transient elastography (FibroScan).
Frequently asked
Plain-language answers about fatty liver, this screener, and what evaluation costs at a Class A hospital in China.
- What is MASLD vs NAFLD?
- MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease) is the new internationally agreed name for what was previously called NAFLD. The criteria centre on hepatic steatosis plus at least one cardiometabolic risk factor (overweight, T2DM, hypertension, dyslipidaemia).
- What's the standard fatty liver workup?
- Liver ultrasound + FibroScan (transient elastography) + ALT, AST, GGT, lipid panel, HbA1c. At a Class A international department this is typically $120–220 all-in. FIB-4 score is calculated from age + AST + ALT + platelets to estimate fibrosis risk.
- Is fatty liver reversible?
- Yes, especially early stage. 7–10% body weight loss reverses steatosis in most patients and improves fibrosis in many. GLP-1 receptor agonists, SGLT2 inhibitors, and pioglitazone all have evidence in MASLD. Resmetirom (Rezdiffra) is the first FDA-approved direct MASH therapy.
About this screener
Risk-factor screener informed by AASLD 2023 MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease) practice guidance. Confirmatory diagnosis requires imaging (ultrasound or MRI-PDFF) and / or transient elastography (FibroScan).
What this screener covers
- Non-alcoholic fatty liver disease (MASLD)(ICD-10 K76.0)
- Non-alcoholic steatohepatitis (MASH)(ICD-10 K75.81)
Validated source
Medical review
Reviewed by Panda Touring Care medical team (Hepatology coordinator review) · last reviewed 2025-04-01
Other self-assessments
Weight loss & GLP-1 candidacy screener
BMI, waist circumference, prior attempts and comorbidities — see whether GLP-1 medication, lifestyle support, or surgical evaluation is the best next step.
Psychiatry · NeurodevelopmentalAdult ADHD self-screener (ASRS-v1.1)
The 6-item Part A of the WHO Adult ADHD Self-Report Scale. Validated screen for adults 18+. Not a diagnosis — but a strong indicator of whether a full evaluation is warranted.
Psychiatry · Mental healthDepression screener (PHQ-9)
The 9-item Patient Health Questionnaire — the most widely used validated depression screener in primary care worldwide. Free, 3 minutes, immediate results.
Psychiatry · Mental healthAnxiety screener (GAD-7)
The 7-item Generalised Anxiety Disorder scale — the standard validated screener for adult anxiety. Free, 2 minutes.
Hepatology · Addiction medicineAlcohol use screener (AUDIT-C)
Three-question alcohol use screener used by the WHO and US Veterans Affairs. Identifies hazardous drinking patterns in under a minute.
Sleep medicineInsomnia severity index (ISI)
Validated 7-item insomnia severity scale. Identifies clinically significant insomnia and tracks treatment response.